Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ap-306 (1 trial)
sevelamer (renagel) (2 trials)
vs-505 (1 trial)
Hyperphosphatemia (Phase 2)
Trials (2 total)
Trial APIs (3 total)